Although improvement in psychosocial functioning is a common goal in
substance-abuse treatment, the primary outcome measure in most
cocaine trials is urinalysis-verified
cocaine use. However, the relationship between
cocaine use and psychosocial outcomes is not well documented. To investigate this relationship and identify the optimal urine-screen method, we retrospectively analyzed data from two 25-week randomized controlled trials of abstinence reinforcement (AR) in 368
cocaine/
heroin users maintained on
methadone.
Cocaine use was measured thrice weekly by qualitative urinalysis,
benzoylecgonine concentration (BE), and an estimate of New Uses of
cocaine by application of an algorithm to BE. Social adjustment (SAS-SR), current diagnosis of
cocaine dependence (DSM-IV criteria), and depression symptoms (Beck Depression Inventory) were determined at study exit.
Cocaine use was significantly lower in AR groups than in controls. Across groups, in-treatment
cocaine use was significantly associated with worse social adjustment, current
cocaine dependence, and depression at exit. Significant differences were detected more frequently with New Uses than qualitative urinalysis or BE. Nevertheless, the amount of variance accounted for by the urine screens was typically <15%.
Cocaine use during treatment, especially when measured with New Uses criteria, can predict psychosocial functioning, but cannot substitute for direct measures of psychosocial functioning.